Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
GLI-2 Double Nickase Plasmid (h): sc-400839-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- GLI-2 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- GLI-2 Double Nickase Plasmid (h) and GLI-2 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting GLI2. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: GLI-2 Antibody (C-10): sc-271786
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GLI-2 Double Nickase Plasmid (h) | sc-400839-NIC | 20 µg | $410.00 | |||
GLI-2 Double Nickase Plasmid (h2) | sc-400839-NIC-2 | 20 µg | $410.00 |
Human GLI2 encodes GLI-2, a zinc-finger transcription factor that functions as a principal effector of canonical Hedgehog signaling downstream of PTCH1 and SMO. Upon pathway activation, GLI-2 regulates transcriptional programs controlling embryonic patterning, cell fate decisions, and context-dependent proliferation and differentiation. GLI2 activity is shaped by post-translational processing and crosstalk with pathways such as TGF-β, WNT/β-catenin, and MAPK, integrating developmental cues with tissue homeostasis. Dysregulated GLI2 signaling has been associated with Hedgehog-pathway–driven oncogenic transcriptional states and developmental abnormalities, making GLI2 a frequent target in studies of morphogen signaling and transcriptional control.
GLI-2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the GLI2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within GLI2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt GLI2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of GLI2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.